Clinical Trial Update: Antidepressant Trial With P2X7 Antagonist JNJ-54175446 [Phase 2]

View source ↗

Summary

Phase 2 trial update for JNJ-54175446 (P2X7 antagonist) in major depressive disorder with inflammation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Major Depressive Disorder

Drugs mentioned

• JNJ-54175446

Snippet

Sponsor: CCTU-Core | Conditions: Depressive Disorder, Major, Inflammation | Phase 2 | Status: UNKNOWN